The idea of QNM Center was formulated after the Kyoto University-UCLA symposium, titled "Harnessing physical forces for medical applications - The Convergence of Physics, Nanomaterials, Cell Biology and Cancer Research", held at California NanoSystems Institute (CNSI) of UCLA.
Led by Fuyuhiko Tamanoi, a program-specific professor at iCeMS and professor at UCLA, we plan to hold symposiums and seminar series at both Kyoto University and UCLA to promote academic exchange, exchange of researchers, and student exchange between the two universities.
By interacting with UCLA, we will also function as an exchange hub between Kyoto University and UCLA, contributing to the two universities' research collaboration.
Fabruary 14, 2022
New paper is published!!
We have reported that PIP-Based KRAS inhibitor KR12 exhibits excellent tumor accumulation properties.
Please see details from here.